Chinese Journal of Clinical Hepatology 2011 Issue 1 Hepatitis C virus infection and its therapeutic drugs

Hepatitis C virus infection and its therapeutic drugs
QI Zhong-tian

..............page:15-18,27

Detection and clinical significance of autoantibodies In patients with chronic hepatitis C in Tianjin
WANG Chun-yan;HU Dong-sheng;LU Wei

..............page:93-95

Preliminary study of HCV mouse model induced by infectious HCV 2a plasmid
lou guo hua ; liu yan ning ; yin chun ben ; chen feng ; jia zhan sheng ; chen zhi

..............page:72-75

Current diagnosis and treatment of hepatorenal syndrome
ZHENG Xiao-li

..............page:107-109

New development of small molecule compounds for hepatitis C therapy
DONG Zhi-xia;XIE Qing

..............page:19-22

Prediction of HLA-DRB1*0311/0401 in recognizing epitopes of HCV Core protein of different genotypes
cheng ling ; hong guo zuo ; guo yan ; mao qing

..............page:61-64

Progress in the development and immunogenicity improvement of DNA vaccine against chronic HCV infection
YIN Xiao;WEN Bo;TAN Wen-jie

..............page:32-35

Construction of HCV minigenome containning IFN-β and investigation of its inhibitory effect on viral replication
yang jing ; lei ying feng ; yin wen ; lv xin ; chen ren an ; an qun xing ; yao min ; jia zhan sheng ; xu zhi kai

..............page:57-60

Construction of eukaryotic expression vector of HCV CTL epitopes and establishment of stable transfected CHO cell line
lv xin ; yin wen ; sun meng ning ; huang xiao jun ; yang jing ; yao min ; xue xiao ping ; jia zhan sheng ; xu zhi kai

..............page:45-48

Incidence and risk factors of hospital-acquired acute liver injury in ICU
he zuo ; wang jin quan ; tao xiao gen ; liu bao ; zhao jin song ; zhang lin lin ; lv shi jin

..............page:96-99,102

zhu bian zhi ci

..............page:前插1

New ideas, challenges and strategies about research on hepatitis C vaccine
jia zhan sheng ; ma li ; wei san hua ; yao zhi qiang

..............page:8-14

The construction of HCV multi-CTL epitopes dendritic cell vaccine and its effect of stimulating T cell response in vitro
zhou yun ; li duan ; chen lin ; zhao fu tao ; ma li ; wang hong ; pan lei ; jia zhan sheng

..............page:40-44

The relationship between connective tissue growth factor and hepatic fibrosis
xie yong peng ; zuo xiu xian ; wu yang ; li ying jin ; zhang zuo

..............page:103-106

Functional assessment of expression of Cre recombinase targeting the liver of transgenic mice regulated by Tet-on and Cre/loxP system
zhao ya ; ma yu ; huang yu xiao ; lan hai yun ; sun meng ning ; lv xin ; yang jing ; lei ying feng ; zhang jian min ; kang jian ; zhao ming gao ; wang ai qin ; yin wen

..............page:81-83

HIV-specific cytotoxic T-lymphocyte responses in patients co-infected with HFV and HCV
kang wen zhen ; huang de dong ; li zuo ; zhuang yan ; di zuo ; zhao ke ; xie yu mei ; sun yong tao

..............page:68-71,80

Association of interleukin 28B(IL28B)polymorphisms with the outcomes of HCV infection
SHI Xiao-dong;JIANG Jing;NIU Jun-qi

..............page:28-31

The immunological evaluation of hepatitis C virus vaccine
GUAN Jie;TAN Wen-jie

..............page:23-27

Antiviral therapy with pegylated interferon alpha-2a plus ribavirin in patients with HCV related cirrhosis and to establish the grading for standard therapy
wei xin ; xie yu mei ; chen lin ; pan lei ; hao chun qiu ; wang jiu ping ; bai xue fan ; jia zhan sheng

..............page:89-92

xin xi dong tai

..............page:35,52,67,75,后插17-后插19

Generation of conditionally controlled transgenic mice expressing hepatitis C virus NS3/4A protease
sun meng ning ; lan hai yun ; ma yu ; zhao ya ; lv xin ; yang jing ; lei ying feng ; yao min ; kang jian ; zhao ming gao ; wang ai qin ; yin wen

..............page:76-80

Packaging, selection and identification of recombinant adenoviruses carrying HCV HLA-A2 restricted compound multi-epitopes antigen
wei san hua ; ren ji hong ; liu li ; jia zhan sheng ; dong zuo ; lin fang ; wang xi ; zhang li jun ; liu zuo yang ; zhang hui zhong

..............page:53-56

Current situation in the research of Gilbert\'s syndrome
ZHU Jun-le;SHI Bin

..............page:110-112

Advance in the research of experimental mouse model for hepatitis C virus
LAN Hai-yun

..............page:36-39

Fluorescent reverse transcription-PCR assay for determination of hepatitis C virus genotypes
guo xin hui ; yan yan ; li zhuo ; yin ji ming

..............page:65-67

Treatment of hepatic encephalopathy and minimal hepatic encephalopathy with L-ornitine-L-aspartate
LI Yu-yuan

..............page:100-102

Detection Of hepatitis C virus infection
YANG Rui-feng;WEI Lai

..............page:1-7

Hepatitis C virus NS5A protein stimulates TLR4 expression
WEN Ming;XIAO Xin-qiang;GONG Guo-zhong

..............page:49-52

Anti-viral therapy with pegylated interferon alpha-2a plus ribavirin in patients co-infected with HBV and HCV
pan lei ; wei xin ; xie yu mei ; hao chun qiu ; wang jiu ping ; jia zhan sheng ; bai xue fan

..............page:84-85,95

Retreatment with pegylated interferon alpha-2a/2b and ribavirin in previous relapsers with chronic hepatitis C
zhu yan ; mao qing ; zhang chang jiang ; sun wei ; hu ya jun ; tan chao xia ; wang xiao hong

..............page:86-88

The guideline of prevention and treatment for chronic hepatitis B (2010 version)

..............page:后插1-后插16